DNA methylation and expression of HLA-DR alpha

Area of Science:

• Immunogenetics
• Molecular Biology
• Cancer Research

Background:

• B-cell lines from T-cell acute lymphocytic leukemia (T-ALL) express HLA-DR antigens, while isogenic T-cells do not.
• Lack of HLA-DR expression in T-cells correlates with undetectable HLA-DR mRNA.
• DNA methylation patterns of the HLA-DR alpha gene differ between HLA-DR expressing B-cells and non-expressing T-cells.

Purpose of the Study:

• To investigate the role of DNA methylation in regulating HLA-DR gene expression in T-ALL.
• To explore the potential of epigenetic modifications in restoring HLA-DR expression in T-ALL.

Main Methods:

• Analysis of HLA-DR alpha DNA sequences and methylation status using restriction enzyme digestion (HpaII) and Southern blotting.
• Treatment of T-ALL cell lines with 5-azacytidine to assess demethylation and gene expression.
• Comparison of methylation and expression patterns in T-ALL cell lines versus T-cell lines from human T-cell leukemia-lymphoma virus (HTLV) associated neoplasias.

Main Results:

• T-ALL T-cells showed methylated HpaII sites within the HLA-DR alpha gene's BglII fragment, correlating with absent DR alpha mRNA.
• 5-azacytidine treatment induced HLA-DR surface antigen, DR alpha mRNA, and partial demethylation in T-ALL T-cells.
• HTLV-associated T-cell lines and HTLV-infected T-cells exhibited partially unmethylated HLA-DR alpha loci and expressed DR antigens.

Conclusions:

• DNA methylation is a key mechanism silencing HLA-DR expression in T-ALL.
• Epigenetic modulation via demethylation can restore HLA-DR expression in T-ALL.
• Post-transcriptional regulation may also contribute to HLA-DR antigen expression modulation.